Breaking news

Nvidia Unleashes Evo 2: The AI Powerhouse For Genetic Research

Nvidia, the U.S.-based AI chip giant, has unveiled Evo 2, the most advanced artificial intelligence system dedicated to biomolecular science. Built-in collaboration with Stanford University and the nonprofit Arc Institute, Evo 2 is set to redefine genetic research, accelerating breakthroughs in medicine and biotechnology.

AI Meets Genomics

Powered by Nvidia DGX Cloud on Amazon Web Services (AWS), Evo 2 is designed to decode the complexities of DNA, RNA, and proteins across a vast spectrum of species. With a dataset of nearly 9 trillion nucleotides—the fundamental units of DNA and RNA—this AI model is poised to revolutionize biological research. Its capabilities extend to predicting protein structures, identifying novel molecules for healthcare and industrial applications, and analyzing the effects of genetic mutations.

Evo 2 is now the largest publicly available AI model for genomic data, offering scientists an unprecedented tool for biological discovery. Researchers can leverage Nvidia’s NIM microservice to generate biological sequences and fine-tune the model using their proprietary datasets via the open-source Nvidia BioNeMo Framework.

Game-Changing Potential

“Evo 2 represents a major milestone for generative genomics,” said Patrick Hsu, cofounder of Arc Institute and assistant professor of bioengineering at UC Berkeley. “By deepening our understanding of life’s fundamental building blocks, we can unlock new possibilities in healthcare and environmental science that were once unimaginable.”

Brian Hie, assistant professor of chemical engineering at Stanford and faculty fellow at the Dieter Schwarz Foundation Stanford Data Science, echoed this sentiment: “With Evo 2, complex biological design becomes more accessible, allowing researchers to develop groundbreaking innovations in a fraction of the time.”

Market Reaction

Despite the breakthrough, Nvidia’s stock dipped 0.2% in after-hours trading on Wednesday, settling at $139 per share, with a market capitalization of $3.4 trillion. However, as AI-driven biotech advances continue to gain momentum, Nvidia’s role in shaping the future of medicine and genomics remains stronger than ever.

Apple Surpasses Nvidia As Investors Reassess The True Cost Of The AI Boom

Apple Reclaims Title As World’s Most Valuable Company

Apple has overtaken Nvidia to become the world’s most valuable publicly traded company again, highlighting a shift in investor sentiment as markets reassess the costs and returns of the artificial intelligence boom.

Apple Regains The Top Spot

Apple (AAPL) ended Monday with a market capitalization of $4.95 trillion, surpassing Nvidia (NVDA), whose valuation fell 5% to $4.77 trillion. It was the first time since April 2025 that Apple closed a trading session ahead of the AI chipmaker.

The move comes ahead of Apple’s quarterly earnings report on Thursday, which investors will closely watch for updates on the company’s AI strategy and broader business performance.

Investors Reassess AI Spending

Nvidia’s decline reflects a broader pullback in AI-related semiconductor stocks as investors increasingly scrutinize the returns on heavy infrastructure spending. The company had held the top valuation since June 2025, when it overtook Microsoft, and briefly surpassed a $5 trillion market capitalization in October.

At the same time, investor interest has broadened beyond graphics processing units to other parts of the AI supply chain, including memory and storage technologies that support expanding data center capacity. Companies such as Micron Technology (MU), SK Hynix and Sandisk (SNDK) have benefited from that shift as demand for AI-related memory and storage infrastructure continues to grow.

Apple’s Capital Strategy Draws Attention

Apple shares have gained 24% so far this year, compared with a 4% increase for Nvidia.

Investors have viewed Apple’s more measured AI spending strategy favorably. Rather than investing heavily in its own AI infrastructure, the company has relied more extensively on leased computing capacity, limiting capital expenditure while continuing to expand its AI capabilities.

The contrast comes as markets increasingly focus on how quickly large AI investments can generate sustainable financial returns.

Earnings In Focus

Apple’s earnings report could also provide an update on the impact of the global memory chip shortage, which has emerged as a growing challenge for hardware manufacturers.

The company raised prices for some Mac and iPad models in June, becoming one of the first major consumer technology companies to publicly reflect higher memory component costs.

Investors will be watching whether Apple can sustain its recent market outperformance as AI-related infrastructure costs continue to rise and supply constraints persist.

Aretilaw firm
eCredo
The Future Forbes Realty Global Properties
Uol

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter